Novo’s Wegovy pill improves weight loss after switch from injections

Novo’s Wegovy pill improves weight loss after switch from injections

People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months, according to an analysis of real-world data the company presented on Wednesday.  Real-world studies evaluate associations and can’t determine causality. But the results suggest that the Wegovy pill may improve upon the initial weight loss people experience…

Read More
Africa: Guterres Urges Faster Action and Financing to Stop Biodiversity Loss

Africa: Congo Basin Loss Could Trigger Water Wars Across Africa – – Ex-Gabon Minister Lee White

Conservation scientist Lee White reflects on four decades spent creating Gabon’s national parks, tackling illegal logging and confronting the failures of global carbon markets. Climate change will trigger wars over water across much of Africa unless the continent protects the Congo Basin, warns former Gabonese environment minister Professor Lee White. White describes the Congo Basin…

Read More
Africans Bear the Brunt of Biodiversity Loss

Africans Bear the Brunt of Biodiversity Loss

For millions across Africa and the developing world, the biodiversity crisis is not an abstract problem – it’s the soil that no longer yields bountiful harvests and the fish that no longer return to coastal waters. But the world spends 30 times more money destroying nature than protecting it, and Africa often lacks the necessary…

Read More
Wegovy weight loss pill launches in the UAE as Novo looks beyond U.S.

Wegovy weight loss pill launches in the UAE as Novo looks beyond U.S.

Novo Nordisk is launching its weight loss pill Wegovy in the United Arab Emirates, the Danish drugmaker said Wednesday, marking its first launch outside the U.S. market. Novo’s approach will be guided by patient demand, the readiness of healthcare professionals, and the strength of healthcare and telehealth infrastructure, said Emil Kongshøj Larsen, executive vice president,…

Read More
Samsung studying how wearables can prevent GLP-1 muscle loss

Samsung studying how wearables can prevent GLP-1 muscle loss

Samsung has announced a collaborative research initiative with the Massachusetts General Hospital (MGH) Diabetes Research Centre to investigate how wearable technology can assist patients on GLP-1 medications in managing muscle loss. The clinical study will leverage the Galaxy Watch 8, which launched last year, alongside the Samsung Health ecosystem. Researchers plan to evaluate the feasibility…

Read More
Data loss prevention in a browser-first world

Data loss prevention in a browser-first world

Paul Stuttard, director, Duxbury Networking. Data loss prevention (DLP) has traditionally focused on protecting sensitive information within the corporate network perimeter. However, this model no longer reflects how modern organisations operate. Today, data is constantly moving between different cloud services, SaaS (software-as-a-service) platforms, remote devices and web-based applications, making the browser a central workspace for…

Read More